ATORVASTATIN CALCIUM
NDC 43063-474, ATORVASTATIN CALCIUM, tablet, film coated, from PD-Rx Pharmaceuticals, Inc..
- Product NDC
- 43063-474
- Status
- Listed
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090548
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43063-474 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATORVASTATIN CALCIUM PROPYLENE GLYCOL SOLVATE10 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43063-474-30 | 43063047430 | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43063-474-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/09c6c750-ae05-459f-83e8-4a9e4fd85212
Use it
Look up 43063-474 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43063-474 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43063-474. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.